/PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to

Nichicon (6996) has released its financial results, reporting operating income of 2,841 million yen, up 292.1% year-on-year. Net sales reached 44,714 million yen (an increase of 12.9% YoY), ordinary i